Home › Vertex cystic fibrosis drug approved for another 500 U.S. patients
 

Keywords :   


Vertex cystic fibrosis drug approved for another 500 U.S. patients

2014-12-29 22:34:29| Biotech - Topix.net

The U.S. Food and Drug Administration has approved Kalydeco by Vertex Pharmaceuticals for use in about 500 more cystic fibrosis patients than previously. Kalydeco is the Boston pharmaceutical company's only approved drug, following it's decision last year to discontinue its hepatitis C drug due to competition.

Tags: us approved drug patients

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.06Atlantic Tropical Weather Outlook
28.06Learning to listen to nursery pigs
28.06Incomes have risen 'at a crawl' says think tank
28.06Eastern North Pacific Tropical Weather Outlook
28.06Are rainy days ahead for cloud computing?
28.06Electric car battery charges in under five minutes in track test
28.06Debt relief orders can write off up to 50,000
27.06Strike could force Tata plant to shut next week
More »